Sort
89,613 grants matching “depression”
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$3,366,147Carlos Zarate · National Institute Of Mental Health · ZIA · FY2024 · MH
Neurobiology and Target Validation of Novel Therapeutic Agents in Mood Disorders
$3,364,910Carlos Zarate · National Institute Of Mental Health · ZIA · FY2023 · MH
Glutamatergic Modulators for Rapid and Sustained Antidepressant Effect
$3,364,910Carlos Zarate · National Institute Of Mental Health · ZIA · FY2023 · MH
Clinical Evaluation of PET Radiotracers
$3,362,515Robert Innis · National Institute Of Mental Health · ZIA · FY2024 · MH
The Center for Accelerating Practices to End Suicide through Technology Translation (CAPES)
$3,360,660Edwin D Boudreaux · Univ Of Massachusetts Med Sch Worcester · P50 · FY2023 · MH
Biophysical Mechanisms of Cortical MicroStimulation
$3,360,184Sydney S Cash · Massachusetts General Hospital · RF1 · FY2023 · NS
Early Life Exposure to Endocrine Disrupting Chemicals and Child Growth, Adiposity, and Neurodevelopment
$3,359,938Assiamira Ferrara · Kaiser Foundation Research Institute · UH3 · FY2018 · OD
Evaluating the Impact of Accessible and Scalable Digital Interventions to Address Co-Occurring Insomnia and Depression in Breast Cancer Survivors Using an Adaptive Design
$3,355,681Philip Chow · University Of Virginia · R01 · FY2025 · CA
Mitochondrial transport and energy metabolism in synaptic transmission and nerve degeneration and regeneration
$3,355,395Zu-Hang Sheng · National Institute Of Neurological Disorders And Stroke · ZIA · FY2020 · NS
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
$3,353,482Steven P Cohen · Johns Hopkins University · UH3 · FY2020 · AR
The Pathophysiology and Treatment of Children with Severe Irritability
$3,351,647Ellen Leibenluft · National Institute Of Mental Health · ZIA · FY2017 · MH
Integrative genetics of behavior with high throughput technologies
$3,330,318David Goldman · National Institute On Alcohol Abuse And Alcoholism · ZIA · FY2009 · AA
PET Radiopharmaceutical Sciences
$3,330,051Victor W Pike · National Institute Of Mental Health · ZIA · FY2011 · MH
Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)
$3,329,591Joseph Grieco · Park Therapeutics, Inc. · UG3 · FY2023 · DA
Multicenter AIDS Cohort Study - Part B (Baltimore Center)
$3,327,323Joseph B. Margolick · Johns Hopkins University · U01 · FY2014 · AI
Development of cebranopadol, a potent dual MOP/NOP agonist, for the treatment of Opioid Use Disorder (OUD)
$3,324,591Joseph Grieco · Park Therapeutics, Inc. · UG3 · FY2024 · DA
UW Practice-based Suicide Prevention Research Center
$3,322,182Katherine Anne Comtois · University Of Washington · P50 · FY2023 · MH
Innovative modeling of the biopsychosocial model in animals: Validation of outcomes for assessing emotional and cognitive domains affected by naturally-occurring chronic pain in dogs
$3,320,159Margaret Elizabeth Gruen · North Carolina State University Raleigh · R01 · FY2024 · AR
Alzheimer's Disease Research Center
$3,318,934Thomas M Wisniewski · New York University School Of Medicine · P30 · FY2020 · AG
Implementing and Personalizing Best-In-Class Opioid-sparing Pain Management for Major Inpatient Surgeries in Children
$3,315,439Senthilkumar Sadhasivam · University Of Pittsburgh At Pittsburgh · U01 · FY2025 · HD
The Center for Enhancing Treatment and Utilization for Depression and Emergent Suicidality (ETUDES) in Pediatric Primary Care
$3,314,851David A. Brent · University Of Pittsburgh At Pittsburgh · P50 · FY2022 · MH
CORE A: Participant Measures and Assessments
$3,307,044Robyn Lorraine Woods · Hennepin Healthcare Research Institute · U19 · FY2022 · AG
Pharmacogenetics of Phase II Drug Metabolizing Enzymes
$3,304,000Richard M Weinshilboum · Mayo Clinic Rochester · U19 · FY2010 · GM
Medicinal Chemistry of Drugs Acting on Central and Peripheral Opioid Receptors
$3,303,010Kenner Rice · National Institute On Drug Abuse · ZIA · FY2024 · DA
East Africa International Epidemiology Database to evaluate AIDS (IeDEA) Regional Consortium
$3,300,000Kara Kay Wools-Kaloustian · Indiana University Indianapolis · U01 · FY2021 · AI